The National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) awarded a $1,949,463 firm fixed-price contract to Chemspeed Technologies Inc., a foreign-owned, for-profit organization, for a Federated Modular Reaction Screening Lab. The contract has a period of performance through December 31, 2025 and does not utilize a set-aside. Chemspeed Technologies specializes in providing automated laboratory systems, instrumentation, and robotic tools to various U.S. federal agencies. The contract was awarded following a total small business set-aside solicitation for a modular reaction screening system with salient characteristics as described in the requirement. The lab will provide automated, standardized reaction preparation, processing, and storage capabilities to support translational research and development at NCATS.
Generated 11/20/24, 9:02 AM